COVID – 19 | Vaccination Update – Day 385

ad
Experimental COVID-19 vaccine
Experimental COVID-19 vaccine

India’s COVID-19 vaccination coverage has reached nearly 169 Crore (1,68,92,38,289) today. More than 42 lakh (42,95,142) Vaccine Doseshave been administered till 7 pm today. More than1.43 Crore (1,43,64,484) Precaution Doses for the identified categories of beneficiaries (HCWs, FLWs and Over 60 years) for COVID vaccination have been administered so far. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10397256
2nd Dose 9895025
Precaution Dose 3603939
FLWs 1st Dose 18400467
2nd Dose 17302261
Precaution Dose 4576725
Age Group 15-18 years 1st Dose 48766821
  2nd Dose 4502331
Age Group 18-44 years 1st Dose 543976172
2nd Dose 413897292
Age Group 45-59 years 1st Dose 200832252
2nd Dose 173528926
Over 60 years 1st Dose 125265634
2nd Dose 108109368
Precaution Dose 6183820
Cumulative 1st dose administered 947638602
Cumulative 2nd dose administered 727235203
Precaution Dose 14364484
Total 1689238289

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 4th February, 2022 (385thDay)
HCWs 1st Dose 261
2nd Dose 3557
Precaution Dose 40599
FLWs 1st Dose 943
2nd Dose 9136
Precaution Dose 174574
Age Group 15-18 years 1st Dose 393168
  2nd Dose 972762
Age Group 18-44 years 1st Dose 470007
2nd Dose 1350088
Age Group 45-59 years 1st Dose 85917
2nd Dose 313381
Over 60 years 1st Dose 59985
2nd Dose 186328
Precaution Dose 234436
Cumulative 1st dose administered 1010281
Cumulative 2nd dose administered 2835252
Precaution Dose 449609
Total 4295142

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Be the first to comment

Leave a Reply